PRISM - Protéomique, réponse inflammatoire et spectrométrie de masse

Type: Research entity evaluation report

Evaluation campaign: 2024-2025 (group E) - Published on: 03/01/2025

Institution(s) concerned: Université de Lille , CHRU - Centre hospitalier régional et universitaire de Lille , Institut national de la santé et de la recherche médicale - INSERM , CLCC - Centre de lutte contre le cancer de Lille - Centre Oscar Lambret

Disciplinary research field: Life and Earth Sciences (SVE) ; SVE3 Microbiology, Virology, Immunity

ERC panel(s): LS7 Diagnostic tools, therapies and public health: aetiology, diagnosis and treatment of disease, public health, epidemiology, pharmacology, clinical medicine, regenerative medicine, medical ethics ; LS4 Physiology, Pathophysiology and Endocrinology: organ physiology, pathophysiology, endocrinology, metabolism, ageing, regeneration, tumorigenesis, cardiovascular disease, metabolic syndrome ; LS2 Genetics, Genomics, Bioinformatics and Systems Biology: genetics, population genetics, molecular genetics, genomics, transcriptomics, proteomics, metabolomics, bioinformatics, computational biology, biostatistics, biological modelling and simulation,

Keywords: Spectrométrie de masse ; Protéomique ; Oncoimmunologie ; Translationnel